Search filters

List of works by Eva Hellström-Lindberg

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial ⬇️

scientific article published on April 12, 2013

A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome

scientific article

A pharmacodynamic study of 5-azacytidine in the P39 cell line

scientific article published on January 2006

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

scientific article

Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts

scientific article published on 10 August 2015

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

scientific article published on 4 November 2011

Approach to anemia associated with myelodysplastic syndromes.

scientific article

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

scientific article

Challenges of phase III trial design for novel treatments in diseases with no standard treatment: the AZA-001 myelodysplasia study model.

scientific article published on 27 October 2013

Clinical and biological implications of driver mutations in myelodysplastic syndromes

scientific article published on 12 September 2013

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).

scientific article

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

scientific article

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

scientific article

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

scientific article published on October 2009

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease

scientific article

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

scientific article published on 10 January 2011

Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions ⬇️

scientific article published on April 2013

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

scientific article

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

scientific article

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

scientific article published on 26 August 2013

Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes

scientific article

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

scientific article

Erythropoiesis stimulating agents and other growth factors in low-risk MDS.

scientific article published on 02 October 2013

Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data

scientific article

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome

scientific article published on 11 April 2016

H-Net, the European Network for Harmonization of Training in Hematology, and its policy ⬇️

scientific article published on November 9, 2012

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes

scientific article published on 8 May 2008

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

scientific article

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

scholarly article

Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy

scientific article

Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.

scientific article published on 12 April 2010

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes

scientific article

Mutations in histone modulators are associated with prolonged survival during azacitidine therapy

scientific article published on 03 March 2016

Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers

scientific article published on 16 July 2009

New clues to the molecular pathogenesis of myelodysplastic syndromes

scientific article

Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

scientific article

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality

scientific article published on 24 September 2016

Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion

scientific article published on 06 July 2010

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations

scientific article published on 24 November 2016

Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

scientific article published on 05 February 2010

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome

scientific article published on 15 March 2022

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

scientific article published on 14 September 2012

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

scientific article

Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis

scientific article published on 24 June 2013

SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells

scientific article published on 20 June 2017

SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM)

scientific article published on 29 April 2020

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia

scientific article

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes

scientific article published on 19 February 2010

Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes

scientific article

Supportive care, growth factors, and new therapies in myelodysplastic syndromes

scientific article published on 20 February 2008

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

scientific article

The role of JAK2 mutations in RARS and other MDS.

scientific article published on January 2008

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts

scientific article

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

scientific article published on 16 October 2012

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

scientific article

deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q).

scientific article

Paulina is supported by:

About Paulina

Help